contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


dagens-aktienyheder-3001-2026-rtx-alk-og-greenmobility

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Equity Research Assistant

Victor Skriver

RTX is an IT company that focuses on the development of wireless communication for industry and healthcare. The services include a wide range of cloud-based services, IP solutions, system integration, and radio systems. In addition, mechanical design is offered adapted for 3D and PABX-integrated solutions. Customers are found among small and medium-sized companies. RTX was founded in 1993 and is headquartered in Nørresundby, Denmark.

ALK is a global specialty pharmaceutical company focused on allergy and allergic asthma. It markets allergy immunotherapy treatments and other products and services for people with allergy and allergy doctors. Headquartered in Hørsholm, Denmark, ALK employs around 2,900 people worldwide and is listed on Nasdaq Copenhagen.


ALK-Abelló

GreenMobility is a Danish company in the Mobility-as-a-Service space. GreenMobility operates a free-floating carsharing business of more than 1,000 electric vehicles across larger cities in Europe, aspiring to grow this number to around 10,000 in 2025.

More than 100,000 people have signed up on the service, and users have access to the GreenMobility cars through the GreenMobility app. With thousands of daily trips, GreenMobility helps reduce congestion in cities with a climate impact.
GreenMobility is listed at OMXC Small Cap in Denmark. The share was transferred to the Nasdaq Main Market in December 2020 from Nasdaq First North.

GreenMobility

Dagens aktienyheder 30/01-2026: RTX, ALK og GreenMobility

RTX var i g&#xe5;r formiddags ude med sit regnskab for 1. kvartal 2025/26, der d&#xe6;kker perioden oktober-december 2025, og som viste en fornuftig toplinje v&#xe6;kst, samt fremgang p&#xe5; bruttomargin og EBITDA. Dog p&#xe5;virkes alle poster negativt af en svagere USD-kurs. Du kan l&#xe6;se mere om regnskabet her, og tilmelde dig vores event med RTX her: <a href="https://www.inderes.dk/analyst-comments/rtx-leverer-en-paen-fremgang-i-q1-202526-trods-negativ-pavirkning-af-fra-en-faldende-usd-kurs">https://www.inderes.dk/analyst-comments/rtx-leverer-en-paen-fremgang-i-q1-202526-trods-negativ-pavirkning-af-fra-en-faldende-usd-kurs</a>
ALK meddelte i g&#xe5;r, at EMA&#x2019;s CHMP har afgivet en positiv udtalelse for EURneffy&#xae; 1 mg, en nasal adrenalinspray til akut behandling af anafylaksi hos b&#xf8;rn i v&#xe6;gtintervallet 15-30 kg. Udtalelsen underst&#xf8;tter en udvidelse af den eksisterende godkendelse og styrker ALK&#x2019;s p&#xe6;diatriske fokus, hvor selskabet allerede har opn&#xe5;et tabletgodkendelser inden for respiratorisk allergi. En endelig EU-godkendelse forventes inden for de kommende m&#xe5;neder og vil, hvis den opn&#xe5;s, udvide den adresserbare patientgruppe og &#xf8;ge det kommercielle potentiale for neffy&#xae; i Europa. Udvidelser af patientgrupper samt nye markeder og produktlanceringer har v&#xe6;ret tr&#xe6;khestene for at selskabet har opjusteret sine hel&#xe5;rsforventninger. To gange og nu forventer at vokse med 13-15 % i 2025. Den 20. februar forventer ALK at offentligg&#xf8;re sit hel&#xe5;rsregnskab, og den 23. afholder vi et event hvor du kan f&#xe5; pr&#xe6;senteret 2025 resultaterne og h&#xf8;re mere om det gode momentum forventes fortsat ind i 2026. Tilmeld dig her: <a href="https://www.inderes.dk/videos/alk-praesentation-af-helarsresultater-for-2025">https://www.inderes.dk/videos/alk-praesentation-af-helarsresultater-for-2025</a>
I g&#xe5;r pr&#xe6;senterede CEO Kasper Gjedsted GreenMobilitys forel&#xf8;bige (ikke-reviderede) tal for 2025 samt de v&#xe6;sentligste drivere bag guidance for 2026, som er p&#xe5; linje med den opdaterede strategi og de nye finansielle m&#xe5;ls&#xe6;tninger om oms&#xe6;tningsv&#xe6;kst p&#xe5; 8-12 % og EBITDA-v&#xe6;kst p&#xe5; 12-16 % frem mod 2028. Pr&#xe6;sentationen blev efterfulgt af en Q&amp;A-session, hvor der is&#xe6;r blev fokuseret ind p&#xe5; risici og muligheder ved selvk&#xf8;rende biler. Se eventet her: <a href="https://www.inderes.dk/videos/greenmobility-presentation-of-preliminary-2025-results-and-2026-guidance">https://www.inderes.dk/videos/greenmobility-presentation-of-preliminary-2025-results-and-2026-guidance</a>
Disclaimer: HC Andersen Capital modtager betaling fra det n&#xe6;vnte selskab for en digital IR abonnementsaftale. Administrerende direkt&#xf8;r for HC Andersen Capital, Tue &#xd8;stergaard, ejer aktier og er bestyrelsesformand for GreenMobility. /Victor Skriver d. 30/01/2026 kl. 08:50.

HC Andersen Capital

<ul><li>RTX rapporterede en solid vækst i toplinjen og forbedringer i bruttomargin og EBITDA for 1. kvartal 2025/26, men resultaterne blev negativt påvirket af en svagere USD-kurs.</li><li>ALK modtog en positiv udtalelse fra EMA’s CHMP for EURneffy® 1 mg, hvilket kan udvide den adresserbare patientgruppe og øge det kommercielle potentiale i Europa.</li><li>GreenMobility præsenterede foreløbige tal for 2025 og guidance for 2026, der er i tråd med strategien om omsætningsvækst på 8-12 % og EBITDA-vækst på 12-16 % frem mod 2028.</li></ul>Dette indhold er genereret af AI. Du kan give feedback om det på Inderes <a href="https://forum.inderes.com/t/inderes-fi-sisallon-kehitysideat/71/last">forum</a>.

Dagens aktienyheder 30/01-2026: RTX, ALK og GreenMobility

Summary

Stay up to date